![]() |
市場調查報告書
商品編碼
1497602
心臟監測與心律管理市場:按產品、最終用戶分類 - 全球預測 2024-2030 年Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), End-User (Ambulatory Center, Home Healthcare, Hospitals) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年心臟監測和心律管理市場規模為198億美元,預計2024年將達207.4億美元,2030年將達277.1億美元,複合年成長率為4.91%。
心臟監測和心律管理是醫療保健的重要領域,涉及評估和管理心電活動和心律。這些技術對於診斷和治療心律不整、心臟病和其他心血管疾病等心臟病患者至關重要。心血管疾病的增加,特別是在人口老化中,正在擴大對心臟監測和心律管理解決方案的需求。改善和擴大醫療基礎設施,特別是在新興國家,使更多人能夠獲得心臟護理技術並擴大市場。心臟監測和節律管理設備的高成本以及心臟監測和節律管理設備的技術挑戰阻礙了市場的成長。無線和遠端監控技術等技術創新的進步預計將使患者無需住院即可接受持續護理,從而創造市場成長機會。這些進步使醫療保健提供者可以更輕鬆地即時監測患者並調整治療。
主要市場統計 | |
---|---|
基準年[2023] | 198億美元 |
預測年份 [2024] | 207.4億美元 |
預測年份 [2030] | 277.1億美元 |
複合年成長率(%) | 4.91% |
區域洞察
由於先進的醫療基礎設施、心血管疾病的高盛行率以及領先的醫療設備公司的存在,美洲地區的心臟監測和心律管理市場保持顯著成長。此外,美國、巴西、墨西哥和加拿大對醫療保健進步和高支出的關注,以及無線和遠端監控等技術的採用,也促進了該地區的強勁成長。由於人口老化加劇、文明病盛行率增加以及醫療保健支出增加等因素,亞太地區心臟監測和心律管理市場正在快速成長。由於醫療基礎設施的改善、可支配收入的增加以及政府對醫療保健現代化的努力,中國、日本和印度等國家正在經歷顯著的成長。歐洲是歐洲、中東和非洲地區市場的主要貢獻者,因為它透過強大的醫療保健系統、高昂的醫療保健成本和嚴格的法規確保高品質的醫療保健標準。受經濟差異和醫療設施使用水準不同的影響,中東和非洲預計將成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在心臟監測和心律管理市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對心臟監測和心律管理市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在心臟監測和節律管理市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[196 Pages Report] The Cardiac Monitoring & Cardiac Rhythm Management Market size was estimated at USD 19.80 billion in 2023 and expected to reach USD 20.74 billion in 2024, at a CAGR 4.91% to reach USD 27.71 billion by 2030.
Cardiac monitoring & cardiac rhythm management are essential areas of healthcare that focus on evaluating and managing the heart's electrical activities and rhythms. These techniques are crucial for diagnosing and treating patients with heart conditions such as arrhythmias, heart attacks, and other cardiovascular issues. The increase in cardiovascular diseases, especially among aging populations, is expanding the need for cardiac monitoring & cardiac rhythm management solutions. Rising improvements and expansions in healthcare infrastructure, especially in emerging countries, enable more people to access cardiac care technologies, thus broadening the market. The high cost of cardiac monitoring & rhythm management devices and availability of technical challenges with cardiac monitoring & cardiac rhythm management devices hampers the market growth. Rising innovations such as wireless and remote monitoring technologies allow patients to receive continuous care without staying in a hospital are expected ro create opportunities for market growth. These advancements make it easier for healthcare providers to monitor patients and adjust treatments in real-time.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.80 billion |
Estimated Year [2024] | USD 20.74 billion |
Forecast Year [2030] | USD 27.71 billion |
CAGR (%) | 4.91% |
Regional Insights
The Americas region holds a substantial growth in the cardiac monitoring & cardiac rhythm management market due to presence of advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and the presence of leading medical device companies. Moreover, the adoption of technologies such as wireless and remote monitoring, along with a focus on healthcare advancements and significant healthcare spending in the U.S., Brazil, Mexico, and Canada, contributes to the robust growth in this region. The APAC region is marked by a rapid growth rate in the cardiac monitoring & cardiac rhythm management market, driven by factors such as the increasing aging population, growing prevalence of lifestyle diseases, and rising healthcare expenditure. Countries such as China, Japan, and India are experiencing significant growth due to improvements in healthcare infrastructure, rising disposable incomes, and governmental initiatives aimed at modernizing healthcare. Europe is a major contributor to the EMEA region's market because of its strong healthcare systems, high healthcare spending, and stringent regulations ensuring high-quality standards. The Middle East and Africa are expected to experience growth influenced by economic disparities and varying levels of access to healthcare facilities.
Market Insights
The market dynamics represent an ever-changing landscape of the Cardiac Monitoring & Cardiac Rhythm Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Abbott's Assert-IQ Cardiac Monitor Receives CE Mark Approval for Enhanced Heart Rhythm Management
Abbott received CE mark approval in Europe for Assert-IQ, an advanced insertable cardiac monitor capable of remotely tracking heart rhythms for up to six years. Equipped with Bluetooth technology, the device facilitates the detection and recording of irregular heartbeats, such as elusive atrial fibrillation episodes, and provides critical data alerts to clinicians to support optimal treatment decisions. [Published On: 2024-03-26]
FDA Approves Medtronic's Innovative Aurora EV-ICD System
Medtronic plc has secured FDA approval for its groundbreaking Aurora EV-ICD MRI SureScan system and associated Epsila EV MRI SureScan defibrillation lead. This advanced technology marks a significant innovation by incorporating the life-saving functionalities of conventional implantable cardioverter-defibrillators while strategically positioning the lead under the breastbone, external to the heart and veins. This arrangement allows the Aurora EV-ICD to deliver vital defibrillation, anti-tachycardia pacing, and preventative backup pacing, maintaining traditional devices' familiar size and durability. [Published On: 2023-09-23]
Advancements in Cardiac Monitoring: The Introduction of Boston Scientific's LUX-Dx II+ ICM System
Boston Scientific introduced the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, an advanced solution for continuous arrhythmia monitoring in patients with conditions such as atrial fibrillation, cryptogenic stroke, and syncope. This innovative device features a dual-stage algorithm that initially detects and subsequently verifies arrhythmias, ensuring only clinically relevant data prompts alerts to healthcare providers. The system's remote programming capabilities enhance patient comfort by adjusting event detection settings and symptom recording without the need for face-to-face visits, streamlining the management process and supporting timely, informed clinical decisions. [Published On: 2023-09-03]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiac Monitoring & Cardiac Rhythm Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cardiac Monitoring & Cardiac Rhythm Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics by Applied Cardiac Systems Inc., Alivecor, Inc., Asahi Kasei Corporation, Baxter International Inc., Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Spandan, Tricog Health, and Zoll Medical Corporation.
Market Segmentation & Coverage
Manual External Defibrillator
Wearable Cardioverter Defibrillator
T-ICD